These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27999271)

  • 1. Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.
    González VM; Martín ME; Fernández G; García-Sacristán A
    Pharmaceuticals (Basel); 2016 Dec; 9(4):. PubMed ID: 27999271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers for Anti-Viral Therapeutics and Diagnostics.
    Kim TH; Lee SW
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamers in diagnostics and treatment of viral infections.
    Wandtke T; Woźniak J; Kopiński P
    Viruses; 2015 Feb; 7(2):751-80. PubMed ID: 25690797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-based therapeutics: new approaches to combat human viral diseases.
    Shum KT; Zhou J; Rossi JJ
    Pharmaceuticals (Basel); 2013 Nov; 6(12):1507-42. PubMed ID: 24287493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances on aptamers targeting Plasmodium and trypanosomatids.
    Moreno M; González VM
    Curr Med Chem; 2011; 18(32):5003-10. PubMed ID: 22050748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Aptamers in Virus Detection and Antiviral Therapy.
    Zou X; Wu J; Gu J; Shen L; Mao L
    Front Microbiol; 2019; 10():1462. PubMed ID: 31333603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer Applications in Emerging Viral Diseases.
    Krüger A; de Jesus Santos AP; de Sá V; Ulrich H; Wrenger C
    Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34203242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.
    Yuan S; Zhang N; Singh K; Shuai H; Chu H; Zhou J; Chow BK; Zheng BJ
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4082-93. PubMed ID: 25918143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers for Viral Detection and Inhibition.
    Chakraborty B; Das S; Gupta A; Xiong Y; T-V V; Kizer ME; Duan J; Chandrasekaran AR; Wang X
    ACS Infect Dis; 2022 Apr; 8(4):667-692. PubMed ID: 35220716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers: molecules of great potential.
    Radom F; Jurek PM; Mazurek MP; Otlewski J; Jeleń F
    Biotechnol Adv; 2013 Dec; 31(8):1260-74. PubMed ID: 23632375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamers as imaging agents.
    Gomes Sda R; Azéma L; Allard M; Toulmé JJ
    Expert Opin Med Diagn; 2010 Nov; 4(6):511-8. PubMed ID: 23496229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of ssDNA aptamers specifically directed against Trachinotus ovatus NNV (GTONNV)-infected cells with antiviral activities.
    Yu Q; Liu M; Wei S; Wu S; Xiao H; Qin X; Su H; Li P
    J Gen Virol; 2019 Mar; 100(3):380-391. PubMed ID: 30698517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Subtype-Specific Diagnostic System for Influenza Virus H3N2 Using a Novel Virus-Based Systematic Evolution of Ligands by Exponential Enrichment (Viro-SELEX).
    Kwon J; Narayan C; Kim C; Han MJ; Kim M; Jang SK
    J Biomed Nanotechnol; 2019 Jul; 15(7):1609-1621. PubMed ID: 31196363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer-siRNA chimeras for HIV.
    Takahashi M; Burnett JC; Rossi JJ
    Adv Exp Med Biol; 2015; 848():211-34. PubMed ID: 25757623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of DNA aptamers that bind to influenza A viruses with high affinity and broad subtype specificity.
    Shiratori I; Akitomi J; Boltz DA; Horii K; Furuichi M; Waga I
    Biochem Biophys Res Commun; 2014 Jan; 443(1):37-41. PubMed ID: 24269231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of novel DNA aptamers against coat protein of grouper nervous necrosis virus (GNNV) with antiviral activities and delivery potential in grouper cells.
    Zhou L; Li P; Yang M; Yu Y; Huang Y; Wei J; Wei S; Qin Q
    Antiviral Res; 2016 May; 129():104-114. PubMed ID: 26892075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress of the aptamer-based antiviral drugs].
    Zhu Y; Lü YH; Yang HY; Lin JS; Wang QZ
    Yao Xue Xue Bao; 2013 Apr; 48(4):447-56. PubMed ID: 23833929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers to Hemagglutinin: A Novel Tool for Influenza Virus Recognition and Neutralization.
    Zavyalova E; Kopylov A
    Curr Pharm Des; 2016; 22(31):4835-4853. PubMed ID: 26845125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in cell-SELEX technology for aptamer selection.
    Kaur H
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2323-2329. PubMed ID: 30059712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamers against pathogenic microorganisms.
    Davydova A; Vorobjeva M; Pyshnyi D; Altman S; Vlassov V; Venyaminova A
    Crit Rev Microbiol; 2016 Nov; 42(6):847-65. PubMed ID: 26258445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.